Dr Craig Smith

Co-Expression Networks Unveiled Long Non-Coding RNAs as Molecular Targets of Drugs Used to Treat Bipolar Disorder

Trang Truong, Chiara Bortolasci, Briana Spolding, Bruna Panizzutti, Zoe Liu, Srisaiyini Kidnapillai, Mark Richardson, Laura Gray, Craig Smith, Olivia Dean, Jee Kim, Michael Berk, Ken Walder

(2022), Vol. 13, pp. 1-12, Frontiers in Pharmacology, Lausanne, Switzerland, C1

Cytokine-inducible SH2 domain containing protein contributes to regulation of adiposity, food intake, and glucose metabolism

W Naser, S Maymand, L Rivera, T Connor, C Liongue, C Smith, K Aston-Mourney, D McCulloch, S McGee, A Ward

(2022), Vol. 36, pp. 1-15, FASEB Journal, London, Eng., C1

Organisation of enkephalin inputs and outputs of the central nucleus of the amygdala in mice

A Viden, S Ch'ng, L Walker, A Shesham, S Hamilton, C Smith, A Lawrence

(2022), Vol. 125, Journal of Chemical Neuroanatomy, Netherlands, C1

Differential Level of RXFP3 Expression in Dopaminergic Neurons Within the Arcuate Nucleus, Dorsomedial Hypothalamus and Ventral Tegmental Area of RXFP3-Cre/tdTomato Mice

L Voglsanger, J Read, S Ch’ng, C Zhang, I Eraslan, L Gray, L Rivera, L Hamilton, R Williams, A Gundlach, C Smith

(2021), Vol. 14, Frontiers in Neuroscience, Switzerland, C1

Farmed mussels: A nutritive protein source, rich in Omega-3 fatty acids, with a low environmental footprint

E Yaghubi, S Carboni, R Snipe, C Shaw, J Fyfe, C Smith, G Kaur, S Tan, D Hamilton

(2021), Vol. 13, Nutrients, Switzerland, C1

Augmented reality in medical education: students' experiences and learning outcomes

P Dhar, T Rocks, R Samarasinghe, G Stephenson, C Smith

(2021), Vol. 26, Medical Education Online, United States, C1

Opioid analgesia and opioid-induced adverse effects: A review

A Paul, C Smith, M Rahmatullah, V Nissapatorn, P Wilairatana, M Spetea, N Gueven, N Dietis

(2021), Vol. 14, Pharmaceuticals, Switzerland, C1

Pioglitazone and deoxyribonucleoside combination treatment increases mitochondrial respiratory capacity in m.3243A>G MELAS cybrid cells

H Burgin, M Sanchez, C Smith, I Trounce, M McKenzie

(2020), Vol. 21, International Journal of Molecular Sciences, Switzerland, C1

Characterization of the relaxin family peptide receptor 3 system in the mouse bed nucleus of the stria terminalis

S Ch'ng, J Fu, R Brown, C Smith, M Hossain, S McDougall, A Lawrence

(2019), Vol. 527, pp. 2615-2633, Journal of comparative neurology, Chichester, Eng., C1

Phenotyping neurons activated in the mouse brain during restoration of salt debt

C Smith, J Cross, I Eraslan, A Attawar, S Ch'ng, P Dhar, R Samarasinghe, L Gray, A Lawrence

(2019), Vol. 101, Journal of Chemical Neuroanatomy, Netherlands, C1

The influence of opioid dependence on salt consumption and related psychological parameters in mice and humans

C Smith, J Garfield, A Attawar, D Lubman, A Lawrence

(2019), Vol. 203, pp. 19-26, Drug and Alcohol Dependence, Ireland, C1

Modulation of high fat diet-induced microbiome changes, but not behaviour, by minocycline

K Hasebe, L Rivera, C Smith, T Allnutt, T Crowley, T Nelson, O Dean, S McGee, K Walder, L Gray

(2019), Vol. 82, pp. 309-318, Brain, Behavior, and Immunity, Netherlands, C1

Salt Appetite, and the Influence of Opioids

C Smith, A Lawrence

(2018), Vol. 43, pp. 3-9, Neurochemical Research, United States, C1

Nucleus incertus corticotrophin-releasing factor 1 receptor signalling regulates alcohol seeking in rats

L Walker, H Kastman, J Koeleman, C Smith, C Perry, E Krstew, A Gundlach, A Lawrence

(2017), Vol. 22, pp. 1641-1654, Addiction Biology, United States, C1

Distribution, physiology and pharmacology of relaxin-3/RXFP3 systems in brain

S Ma, C Smith, A Blasiak, A Gundlach

(2017), Vol. 174, pp. 1034-1048, British Journal of Pharmacology, England, C1

Relaxin-3 inputs target hippocampal interneurons and deletion of hilar relaxin-3 receptors in "floxed-RXFP3" mice impairs spatial memory

M Haidar, G Guèvremont, C Zhang, R Bathgate, E Timofeeva, C Smith, A Gundlach

(2017), Vol. 27, pp. 529-546, Hippocampus, United States, C1

Relaxin-3/RXFP3 signalling in mouse hypothalamus: no effect of RXFP3 activation on corticosterone, despite reduced presynaptic excitatory input onto paraventricular CRH neurons in vitro

C Zhang, D Baimoukhametova, C Smith, J Bains, A Gundlach

(2017), Vol. 234, pp. 1725-1739, Psychopharmacology, Berlin, Germany, C1

Endogenous central amygdala mu-opioid receptor signaling promotes sodium appetite in mice

C Smith, L Walker, T Leeboonngam, M McKinley, D Denton, A Lawrence

(2016), Vol. 113, pp. 13893-13898, Proceedings of the national academy of sciences of the United States of America, Washington, D.C., C1

Sensitivity to chronic methamphetamine administration and withdrawal in mice with relaxin-3/RXFP3 deficiency

M Haidar, M Lam, B Chua, C Smith, A Gundlach

(2016), Vol. 41, pp. 481-491, Neurochemical research, New York, N.Y., C1-1

Involvement of central relaxin-3 signalling in sodium (salt) appetite

C Smith, L Walker, B Chua, M McKinley, A Gundlach, D Denton, A Lawrence

(2015), Vol. 100, pp. 1064-1072, Experimental physiology, Chichester, Eng., C1-1

Relaxin-3 receptor (Rxfp3) gene deletion reduces operant sucrose- but not alcohol-responding in mice

A Walker, C Smith, A Gundlach, A Lawrence

(2015), Vol. 14, pp. 625-634, Genes, brain and behavior, Hoboken, N.J., C1-1

Central relaxin-3 receptor (RXFP3) activation reduces elevated, but not basal, anxiety-like behaviour in C57BL/6J mice

C Zhang, B Chua, A Yang, F Shabanpoor, M Hossain, J Wade, K Rosengren, C Smith, A Gundlach

(2015), Vol. 292, pp. 125-132, Behavioural brain research, Amsterdam, The Netherlands, C1-1

Relaxin-3 receptor (RXFP3) signalling mediates stress-related alcohol preference in mice

A Walker, C Smith, B Chua, E Krstew, C Zhang, A Gundlach, A Lawrence

(2015), Vol. 10, pp. 1-71, PLoS One, San Francisco, Calif., C1-1

Relaxin-3 receptor (Rxfp3) gene knockout mice display reduced running wheel activity: implications for role of relaxin-3/RXFP3 signalling in sustained arousal

I Hosken, S Sutton, C Smith, A Gundlach

(2015), Vol. 278, pp. 167-175, Behavioural brain research, Amsterdam, The Netherlands, C1-1

Central injection of relaxin-3 receptor (RXFP3) antagonist peptides reduces motivated food seeking and consumption in C57BL/6J mice

C Smith, B Chua, C Zhang, A Walker, M Haidar, D Hawkes, F Shabanpoor, M Hossain, J Wade, K Rosengren, A Gundlach

(2014), Vol. 268, pp. 117-126, Behavioural brain research, Amsterdam, The Netherlands, C1-1

Relaxin-3/RXFP3 networks: an emerging target for the treatment of depression and other neuropsychiatric diseases?

C Smith, A Walker, I Hosken, B Chua, C Zhang, M Haidar, A Gundlach

(2014), Vol. 5, pp. 1-17, Frontiers in pharmacology, Lausanne, Switzerland, C1-1

Synthesis of fluorescent analogs of relaxin family peptides and their preliminary in vitro and in vivo characterization

L Chan, C Smith, B Chua, F Lin, R Bathgate, F Separovic, A Gundlach, M Hossain, J Wade

(2013), Vol. 1, pp. 1-9, Frontiers in chemistry, Lausanne, Switzerland, C1-1

Chemical synthesis and orexigenic activity of rat/mouse relaxin-3

M Hossain, C Smith, P Ryan, E Büchler, R Bathgate, A Gundlach, J Wade

(2013), Vol. 44, pp. 1529-1536, Amino Acids, Wien, Austria, C1-1

Potential hypothalamic targets of relaxin-3 innervation: a perspective

C Smith, B Chua, A Walker, A Gundlach

(2013), Vol. 118, pp. 47-51, Italian journal of anatomy and embryology, Firenze, Italy, C1-1

Pharmacological activation of RXFP3 is not orexigenic in C57BL/6J mice

C Smith, I Hosken, N Downer, B Chua, M Hossain, J Wade, A Gundlach

(2013), Vol. 118, pp. 52-55, Italian journal of anatomy and embryology, Firenze, Italy, C1-1

Consequences of relaxin-3 null mutation in mice on food-entrainable arousal

I Hosken, C Smith, B Chua, A Gundlach

(2013), Vol. 118, pp. 37-41, Ital J Anat Embryol, Italy, C1-1

Viral-mediated delivery of an RXFP3 agonist into brain promotes arousal in mice

C Smith, A Blasiak, D Ganella, B Chua, S Layfield, R Bathgate, A Gundlach

(2013), Vol. 118, pp. 42-46, Italian journal of anatomy and embryology, Firenze, Italy, C1-1

Relaxin-3 null mutation mice display a circadian hypoactivity phenotype

C Smith, I Hosken, S Sutton, A Lawrence, A Gundlach

(2012), Vol. 11, pp. 94-104, Genes, brain and behavior, Hoboken, N.J., C1-1

Relaxin-3 systems in the brain--the first 10 years

C Smith, P Ryan, I Hosken, S Ma, A Gundlach

(2011), Vol. 42, pp. 262-275, Journal of chemical neuroanatomy, Amsterdam, The Netherlands, C1-1

Distribution of relaxin-3 and RXFP3 within arousal, stress, affective, and cognitive circuits of mouse brain

C Smith, P-J Shen, A Banerjee, P Bonaventure, S Ma, R Bathgate, S Sutton, A Gundlach

(2010), Vol. 518, pp. 4016-4045, Journal of comparative neurology, Chichester, Eng., C1-1

Relaxin family peptides and receptors in mammalian brain

A Gundlach, S Ma, Q Sang, P-J Shen, L Piccenna, K Sedaghat, C Smith, R Bathgate, A Lawrence, G Tregear, J Wade, D Finkelstein, P Bonaventure, C Liu, T Lovenberg, S Sutton

(2009), Vol. 1160, pp. 226-235, Ann N Y Acad Sci, United States, C1-1

Eve-3: a liver enriched suppressor of Ras/MAPK signaling

J King, N Corcoran, G D'Abaco, A Straffon, C Smith, C Poon, M Buchert, S I, N Hall, P Lock, C Hovens

(2006), Vol. 44, pp. 758-767, Journal of hepatology, Amsterdam, The Netherlands, C1-1

Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice

M Lassila, K Jandeleit-Dahm, K Seah, C Smith, A Calkin, T Allen, M Cooper

(2005), Vol. 16, pp. 363-373, Journal of the American society of nephrology, [Washington, D.C.], C1-1

Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects

A Calkin, J Forbes, C Smith, M Lassila, M Cooper, K Jandeleit-Dahm, T Allen

(2005), Vol. 25, pp. 1903-1909, Arteriosclerosis, thrombosis, and vascular biology, Dallas, Tex., C1-1